A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.

[1]  A. von Eckardstein,et al.  Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. , 1997, Journal of lipid research.

[2]  A. vonEckardstein.  Cholesterol efflux from macrophages and other cells. , 1996 .

[3]  D. Sviridov,et al.  Identification of a sequence of apolipoprotein A-I associated with the efflux of intracellular cholesterol to human serum and apolipoprotein A-I containing particles. , 1996, Biochemistry.

[4]  A. von Eckardstein,et al.  Effects of the apolipoprotein E polymorphism on uptake and transfer of cell-derived cholesterol in plasma. , 1995, The Journal of clinical investigation.

[5]  Y. Marcel,et al.  Apolipoprotein A-I Conformation in Reconstituted Discoidal Lipoproteins Varying in Phospholipid and Cholesterol Content (*) , 1995, The Journal of Biological Chemistry.

[6]  S. Yokoyama,et al.  Independent Regulation of Cholesterol Incorporation into Free Apolipoprotein-mediated Cellular Lipid Efflux in Rat Vascular Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.

[7]  G. Assmann,et al.  HDL3 stimulates multiple signaling pathways in human skin fibroblasts. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[8]  G. Anantharamaiah,et al.  Structural models of human apolipoprotein A-I. , 1995, Biochimica et biophysica acta.

[9]  S. Yokoyama,et al.  Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. , 1995, Biochemistry.

[10]  H. Brewer,et al.  Carboxyl-terminal Domain Truncation Alters Apolipoprotein A-I in Vivo Catabolism (*) , 1995, The Journal of Biological Chemistry.

[11]  C. Fielding,et al.  Molecular physiology of reverse cholesterol transport. , 1995, Journal of lipid research.

[12]  G. Assmann,et al.  Physiological role and clinical relevance of high‐density lipoprotein subclasses , 1994, Current opinion in lipidology.

[13]  A. Mendez,et al.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol. , 1994, The Journal of clinical investigation.

[14]  P. Duchateau,et al.  Structural domain of apolipoprotein A-I involved in its interaction with cells. , 1994, Biochimica et biophysica acta.

[15]  L. Curtiss,et al.  Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. , 1994, The Journal of biological chemistry.

[16]  M C Phillips,et al.  The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins. , 1994, The Journal of biological chemistry.

[17]  C. Fielding,et al.  Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. , 1993, Biochemistry.

[18]  A. von Eckardstein,et al.  Structural and functional properties of natural and chemical variants of apolipoprotein A-I. , 1993, Biochimica et biophysica acta.

[19]  P. Duchateau,et al.  Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg). , 1993, The Journal of biological chemistry.

[20]  L. Curtiss,et al.  Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase. , 1991, The Journal of biological chemistry.

[21]  A. Jonas.  Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. , 1991, Biochimica et biophysica acta.

[22]  A. Mendez,et al.  Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. , 1991, The Journal of biological chemistry.

[23]  A. von Eckardstein,et al.  Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants. , 1991, Journal of lipid research.

[24]  A. von Eckardstein,et al.  A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities. , 1991, The Journal of clinical investigation.

[25]  J. Frohlich,et al.  Lecithin:cholesterol acyltransferase in familial HDL deficiency (Tangier disease). , 1988, Biochimica et biophysica acta.

[26]  G. Assmann,et al.  Simplified Turbidimetric Determination of Apolipoproteins A-I, A-II and B Using a Microtitre Method , 1988, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[27]  M. Dobiášová.  Lecithin: cholesterol acyltransferase and the regulation of endogenous cholesterol transport. , 1983, Advances in lipid research.

[28]  G. Assmann,et al.  The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins. , 1977, The Journal of clinical investigation.